• Annexin V Enables Early In Vivo Detection of Cardiomyocyte D

  2026-06-23

  The reference study demonstrates that labeled recombinant human Annexin V detects early cardiomyocyte cell death in a mouse model of myocardial ischemia/reperfusion (I/R). This work establishes Annexin V as a sensitive in situ marker for phosphatidylserine externalization, with critical implications for mapping the temporal dynamics of apoptosis and evaluating cell death–blocking strategies in cardiac research.

• 2-Deoxy-D-glucose: Mechanistic Leverage for Metabolic Resear

  2026-06-23

  Explore how 2-Deoxy-D-glucose (2-DG) enables translational researchers to dissect and strategically manipulate cellular metabolism. This article connects the latest mechanistic insights on glycolysis inhibition, lactate signaling, and metabolic stress with actionable guidance for cancer, virology, and immunometabolic studies. We benchmark APExBIO’s 2-DG against the evolving scientific landscape, highlight protocol best practices, and offer a forward-looking perspective on cross-domain opportunities in metabolic therapeutics.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Workf

  2026-06-22

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) is designed to prevent protein degradation during extraction and analysis workflows, especially where divalent cation compatibility is required. This article details how to integrate this broad-spectrum inhibitor into protein extraction, Western blotting, and co-immunoprecipitation workflows, while clarifying boundaries such as its inapplicability for metalloprotease inhibition. Use cases, limitations, and troubleshooting tips are provided for accurate and reproducible protein science.

• ABT-263 (Navitoclax): Precision Tools for Apoptosis Quantifi

  2026-06-22

  Discover how ABT-263 (Navitoclax) is transforming apoptosis quantification in cancer biology research. This article delves into advanced assay design, evidence-based metrics, and practical insights from recent systems biology breakthroughs.

• Pharmacogenomics of Chloroquine & Hydroxychloroquine: System

  2026-06-21

  This article reviews Biswas & Sukasem's systematic synthesis of pharmacogenomic evidence for chloroquine and hydroxychloroquine. Their analysis clarifies how cytochrome P450 genetic variability shapes drug safety and efficacy, underscoring the need for genotype-guided therapy and highlighting practical implications for drug development and personalized medicine.

• AAPH: Precision Oxidative Stress Modeling with 2,2'-Azobis(2

  2026-06-20

  AAPH stands out as a gold-standard, water-soluble oxidative stress inducer, enabling reproducible lipid peroxidation and hemolysis models in vitro. Recent advances, such as the hazelnut protein oxidation study, showcase how AAPH empowers nuanced exploration of redox biology, functional protein analysis, and antioxidant screening.

• Malate ((S)-2-hydroxysuccinic acid) in Immunometabolism Assa

  2026-06-19

  Malate, a pivotal TCA cycle intermediate, enables precise dissection of metabolic flux and immunometabolic crosstalk in cancer and macrophage research. This guide illustrates how to optimize malate-based protocols for mitochondrial, metabolic, and immune functional assays, with troubleshooting advice and insights from cutting-edge cholangiocarcinoma studies.

• 8-Chloroadenosine: Precision Tool for RNA Metabolism Study

  2026-06-19

  8-Chloroadenosine stands out as a high-purity nucleoside analog for dissecting transcriptional regulation and RNA metabolism in cancer and molecular biology research. Its unique solubility, stability, and validated performance streamline complex workflows, particularly for lncRNA and IL-6 pathway interrogation in NSCLC models.

• LLY-507: Selective SMYD2 Inhibitor for Cancer & Fibrosis Res

  2026-06-18

  LLY-507 stands out as a potent, highly selective SMYD2 inhibitor, enabling researchers to dissect epigenetic mechanisms in cancer and fibrosis with unprecedented precision. This article bridges robust bench workflows, troubleshooting guidance, and translational insight, spotlighting LLY-507’s reliability in cell-based assays and disease models.

• ORAI2-Mediated SOCE Drives Early Salivary Gland Fibrosis Pos

  2026-06-18

  This study identifies ORAI2 as a pivotal regulator of early-stage postirradiation fibrosis in salivary glands via a newly defined ORAI2/JNK/NFAT1/TGF-β1 axis. Targeting store-operated calcium entry (SOCE) and NFAT1 mitigates fibrosis and restores gland function, providing new molecular targets for intervention.

• Fenofibrate as a PPARα Agonist: Protocols for Liver & Cancer

  2026-06-17

  Fenofibrate stands out as a potent PPARα agonist that enables robust modeling of lipid metabolism and cancer signaling pathways. Learn how to optimize your workflow for precise, reproducible results while leveraging the latest insights into age-independent PPARα-YAP pathway activation.

• Prolonging Mouse Corneal Epithelial Cell Proliferation In Vi

  2026-06-17

  The reference study introduces a novel 6C medium containing targeted small molecule modulators, including the Wnt production inhibitor IWP-2, to sustain mouse corneal epithelial cell (mCEC) proliferation and suppress unwanted epithelial-mesenchymal transdifferentiation. This paradigm supports more efficient ex vivo expansion of progenitor cells for regenerative research and transplantation.

• Practical Insights: Iptacopan (LNP023) for Complement Pathwa

  2026-06-16

  This scenario-driven article examines real laboratory challenges in complement-mediated hemolysis and cell viability assays, demonstrating how Iptacopan (LNP023, SKU C8699) from APExBIO delivers reproducible results and clinical-grade reliability. Data-backed answers and workflow guidance are provided for experimental design, optimization, and product selection.

• Technical Guidance for Oligo (dT) 25 Beads in mRNA Purificat

  2026-06-16

  Oligo (dT) 25 Beads streamline eukaryotic mRNA isolation by selectively capturing polyA-tailed transcripts, supporting workflows such as RT-PCR, first-strand cDNA synthesis, and next-generation sequencing. These superparamagnetic beads are best suited for researchers requiring high-purity mRNA from total RNA or directly from cells and tissues. They are not intended for non-polyadenylated RNA species or prokaryotic mRNA workflows.

• AML Sensitivity to Mitocans: Mechanisms and Caspase-1 Pathwa

  2026-06-15

  The reference study uncovers why acute myeloid leukemia (AML) exhibits heightened sensitivity to mitochondrial-targeted anticancer drugs (mitocans), linking this vulnerability to specific mitochondrial defects in AML cells. These findings refine our understanding of mitochondrial metabolism in cancer and have practical implications for designing selective, mitochondria-based therapies.

15177 records 1/1012 page Next 12345 下5页 Last page